Trial Profile
A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Dose Study To Investigate The Effects Of 8 Mg Fesoterodine SR Tablets And 10 Mg Solifenacin Tablet On Gastrointestinal Transit In Healthy Female Subjects.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2013
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary) ; Solifenacin
- Indications Overactive bladder
- Focus Pharmacodynamics
- Sponsors Pfizer
- 07 Feb 2013 New source identified and integrated (Mayo Clinic; 09-000944).
- 23 Dec 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov (NCT00832650).
- 23 Dec 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov (NCT00832650).